Arkolith/Insider Trading/ELVN/Form 4

Hohl Benjamin

CHIEF FINANCIAL OFFICEREnliven Therapeutics, Inc. (ELVN) · full profile →Form 4 · filed Oct 1, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$66K
Net Open-Market Flow
-$66K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 29, 2025Sell(S)3K$20.40$66K23K
Sep 29, 2025Option exercise(M)3K$2.48$8K26K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 29, 2025Option exercise(M)3K—$0105K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001882764-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML